PA8580301A1 - Nuevos derivados de benzoimidazol utiles como agentes antiproliferativos - Google Patents
Nuevos derivados de benzoimidazol utiles como agentes antiproliferativosInfo
- Publication number
- PA8580301A1 PA8580301A1 PA8580301A PA8580301A PA8580301A1 PA 8580301 A1 PA8580301 A1 PA 8580301A1 PA 8580301 A PA8580301 A PA 8580301A PA 8580301 A PA8580301 A PA 8580301A PA 8580301 A1 PA8580301 A1 PA 8580301A1
- Authority
- PA
- Panama
- Prior art keywords
- new
- derivatives useful
- antiproliferative agents
- compounds
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Abstract
LA INVENCION SE REFIERE A COMPUESTOS DE FORMULA 1 Y A SALES, PROFARMACOS, Y SOLVATOS FARMACEUTICAMENTE ACEPTABLES DE LOS MISMOS, DONDE R1,R2,R3 Y R4 SON COMO SE HAN DEFINIDO ANTERIORMENTE. LA INVENCION TAMBIEN SE REFIERE A PROCEDIMIENTOS PARA TRATAR EL CRECIMIENTO CELULAR ANORMAL, TAL COMO CANCER, EN MAMIFEROS ADMINISTRANDO LOS COMPUESTOS DE FORMULA 1 Y A COMPOSICIONES FARMACEUTICAS PARA TRATAR TALES TRASTORNOS QUE CONTIENEN LOS COMPUESTOS DE FORMULA 1. LA INVENCION TAMBIEN SE REFIERE A PROCEDIMIENTOS PARA PREPARAR LOS COMPUESTOS DE FORMULA 1.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US40652402P | 2002-08-28 | 2002-08-28 | |
US41704702P | 2002-10-08 | 2002-10-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
PA8580301A1 true PA8580301A1 (es) | 2005-05-24 |
Family
ID=31981411
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PA8580301A PA8580301A1 (es) | 2002-08-28 | 2003-08-12 | Nuevos derivados de benzoimidazol utiles como agentes antiproliferativos |
Country Status (41)
Country | Link |
---|---|
US (1) | US7071337B2 (es) |
EP (1) | EP1594858B1 (es) |
JP (1) | JP4551771B2 (es) |
KR (2) | KR20070086768A (es) |
CN (1) | CN1319966C (es) |
AP (1) | AP2005003237A0 (es) |
AR (1) | AR041055A1 (es) |
AT (1) | ATE445610T1 (es) |
AU (1) | AU2003250499B2 (es) |
BR (1) | BRPI0313942C1 (es) |
CA (1) | CA2495577C (es) |
CR (1) | CR7698A (es) |
CU (1) | CU23413B7 (es) |
CY (1) | CY1110580T1 (es) |
DE (1) | DE60329715D1 (es) |
DK (1) | DK1594858T3 (es) |
DO (1) | DOP2003000694A (es) |
EA (1) | EA008448B1 (es) |
EC (1) | ECSP055633A (es) |
ES (1) | ES2333219T3 (es) |
GE (1) | GEP20064005B (es) |
HK (1) | HK1078571A1 (es) |
HN (1) | HN2003000257A (es) |
HR (1) | HRP20050191B1 (es) |
IL (1) | IL166832A (es) |
IS (1) | IS2738B (es) |
MA (1) | MA27389A1 (es) |
MX (1) | MXPA05001256A (es) |
MY (1) | MY139357A (es) |
NO (1) | NO20051303L (es) |
NZ (1) | NZ538427A (es) |
OA (1) | OA12916A (es) |
PA (1) | PA8580301A1 (es) |
PE (1) | PE20050131A1 (es) |
PL (1) | PL377678A1 (es) |
PT (1) | PT1594858E (es) |
RS (1) | RS20050180A (es) |
SI (1) | SI1594858T1 (es) |
TW (1) | TW200407131A (es) |
UY (1) | UY27952A1 (es) |
WO (1) | WO2004020431A2 (es) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100787649B1 (ko) * | 2003-06-24 | 2007-12-21 | 화이자 프로덕츠 인크. | 1-[(벤조이미다졸-1-일)퀴놀린-8-일]피페리딘-4-일아민유도체의 제조 방법 |
CA2561516A1 (en) * | 2004-03-30 | 2005-10-13 | Pfizer Products Inc. | Combinations of signal transduction inhibitors |
GB0411421D0 (en) * | 2004-05-21 | 2004-06-23 | Glaxo Group Ltd | Novel compounds |
MX2007004183A (es) * | 2004-10-07 | 2007-06-07 | Pfizer Prod Inc | Derivados de benzoimidazol utiles como agentes antiproliferacion. |
EP2444419A1 (en) | 2005-04-26 | 2012-04-25 | Pfizer Inc. | P-Cadherin antibodies |
JP5161777B2 (ja) | 2005-09-07 | 2013-03-13 | アムジェン フレモント インク. | アクチビン受容体様キナーゼ−1に対するヒトモノクローナル抗体 |
UA91129C2 (ru) | 2006-05-09 | 2010-06-25 | Пфайзер Продактс Инк. | Производные циклоалкиламинокислот и фармацевтическая композиция, которая их содержит |
CN101679423A (zh) | 2007-04-03 | 2010-03-24 | 阵列生物制药公司 | 作为受体酪氨酸激酶抑制剂的咪唑并[1,2-a]吡啶化合物 |
MY187131A (en) * | 2008-05-21 | 2021-09-02 | Incyte Corp | Salts of 2-fluoro-n-methyl-4-[7-(quinolin-6-yl-methyl)-imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide and processes related to preparing the same |
US9526648B2 (en) | 2010-06-13 | 2016-12-27 | Synerz Medical, Inc. | Intragastric device for treating obesity |
US8628554B2 (en) | 2010-06-13 | 2014-01-14 | Virender K. Sharma | Intragastric device for treating obesity |
US10010439B2 (en) | 2010-06-13 | 2018-07-03 | Synerz Medical, Inc. | Intragastric device for treating obesity |
US10420665B2 (en) | 2010-06-13 | 2019-09-24 | W. L. Gore & Associates, Inc. | Intragastric device for treating obesity |
EP2611808B1 (en) | 2010-09-02 | 2014-11-12 | Merck Patent GmbH | Pyrazolopyridinone derivatives as lpa receptor antagonists |
GB201103578D0 (en) | 2011-03-02 | 2011-04-13 | Sabrepharm Ltd | Dipyridinium derivatives |
JP6407504B2 (ja) | 2012-09-21 | 2018-10-17 | アログ・ファーマシューティカルズ・インコーポレイテッドArog Pharmaceuticals,Inc. | 恒常的に活性であるリン酸化型flt3キナーゼの阻害方法 |
US10835525B2 (en) | 2012-09-26 | 2020-11-17 | Arog Pharmaceuticals, Inc. | Method of inhibiting mutant C-KIT |
TWI599356B (zh) | 2012-09-26 | 2017-09-21 | 安羅格製藥有限責任公司 | 抑制突變型c-kit的方法 |
US11642340B2 (en) | 2012-09-26 | 2023-05-09 | Arog Pharmaceuticals, Inc. | Method of inhibiting mutant C-KIT |
BR112015016282A2 (pt) | 2013-01-07 | 2017-07-11 | Arog Pharmaceuticals Inc | crenolanibe para tratamento de distúrbios proliferativos de flt3 mutado |
US10463658B2 (en) | 2013-10-25 | 2019-11-05 | Videra Pharmaceuticals, Llc | Method of inhibiting FLT3 kinase |
TR201900148T4 (tr) * | 2014-10-31 | 2019-02-21 | Genoscience Pharma Sas | Kansere karşı yeni maddeler olarak sübstitüe edilmiş 2,4 diamino-kinolin. |
GB2543550A (en) | 2015-10-21 | 2017-04-26 | Hox Therapeutics Ltd | Peptides |
US10779980B2 (en) | 2016-04-27 | 2020-09-22 | Synerz Medical, Inc. | Intragastric device for treating obesity |
SI3452465T1 (sl) | 2016-05-04 | 2021-04-30 | Genoscience Pharma | Substituirani derivati 2,4-diamino-kinolina za uporabo v zdravljenju proliferativnih bolezni |
PE20191238A1 (es) | 2016-11-02 | 2019-09-11 | Arog Pharmaceuticals Inc | Crenolanib para tratar mutaciones asociadas con trastornos proliferativos con flt3 mutado |
CN107382983B (zh) * | 2017-08-24 | 2020-08-07 | 扬州市三药制药有限公司 | 一种治疗白血病药物的合成方法 |
CN107382984B (zh) * | 2017-08-24 | 2020-07-10 | 扬州市三药制药有限公司 | 一种治疗白血病药物的制备方法 |
CN110840893A (zh) | 2018-12-13 | 2020-02-28 | 安罗格制药有限责任公司 | 含克莱拉尼的药物组合物及其用途 |
US11471451B2 (en) | 2019-08-19 | 2022-10-18 | Arog Pharmaceuticals, Inc. | Uses of crenolanib |
CN117447376A (zh) * | 2019-12-09 | 2024-01-26 | 苏州恩华生物医药科技有限公司 | 连双环结构sigma-1受体抑制剂 |
US11713310B2 (en) | 2020-07-20 | 2023-08-01 | Arog Pharmaceuticals, Inc. | Crystal forms of crenolanib and methods of use thereof |
US20240025892A1 (en) * | 2020-08-05 | 2024-01-25 | The General Hospital Corporation | Salt inducible kinase inhibitors |
US11524006B2 (en) | 2020-09-17 | 2022-12-13 | Arog Pharmaceuticals, Inc. | Crenolanib for treating TRK kinase associated proliferative disorders |
CN113683594B (zh) * | 2021-09-07 | 2022-12-27 | 曲靖师范学院 | 一种喹啉-苯并咪唑盐类化合物及其合成方法和应用 |
JP2023063189A (ja) | 2021-10-22 | 2023-05-09 | アログ・ファーマシューティカルズ・インコーポレイテッド | 以前の治療に対して再発性/不応性のflt3突然変異増殖性障害を治療するためのクレノラニブ |
WO2023081923A1 (en) | 2021-11-08 | 2023-05-11 | Frequency Therapeutics, Inc. | Platelet-derived growth factor receptor (pdgfr) alpha inhibitors and uses thereof |
CN114409632A (zh) * | 2022-02-22 | 2022-04-29 | 广西师范大学 | 2-取代氨基-3-苯并咪唑取代的喹啉衍生物及其制备方法与应用 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8607683D0 (en) | 1986-03-27 | 1986-04-30 | Ici Plc | Anti-tumor agents |
US5990146A (en) | 1997-08-20 | 1999-11-23 | Warner-Lambert Company | Benzimidazoles for inhibiting protein tyrosine kinase mediated cellular proliferation |
JP2001518470A (ja) | 1997-09-26 | 2001-10-16 | メルク エンド カムパニー インコーポレーテッド | 新規な血管形成阻害剤 |
UA75055C2 (uk) * | 1999-11-30 | 2006-03-15 | Пфайзер Продактс Інк. | Похідні бензоімідазолу, що використовуються як антипроліферативний засіб, фармацевтична композиція на їх основі |
WO2001040214A1 (en) * | 1999-11-30 | 2001-06-07 | The Board Of Trustees Of The Leland Stanford Junior University | Bryostatin analogues, synthetic methods and uses |
JP2008002005A (ja) * | 2006-06-21 | 2008-01-10 | Shimada Shoji Kk | 衣服用パッド |
-
2003
- 2003-08-12 PA PA8580301A patent/PA8580301A1/es unknown
- 2003-08-14 NZ NZ538427A patent/NZ538427A/en not_active IP Right Cessation
- 2003-08-14 ES ES03791110T patent/ES2333219T3/es not_active Expired - Lifetime
- 2003-08-14 SI SI200331687T patent/SI1594858T1/sl unknown
- 2003-08-14 JP JP2004569727A patent/JP4551771B2/ja not_active Expired - Lifetime
- 2003-08-14 CA CA 2495577 patent/CA2495577C/en not_active Expired - Lifetime
- 2003-08-14 DE DE60329715T patent/DE60329715D1/de not_active Expired - Lifetime
- 2003-08-14 CN CNB038206218A patent/CN1319966C/zh not_active Expired - Lifetime
- 2003-08-14 AT AT03791110T patent/ATE445610T1/de active
- 2003-08-14 DK DK03791110T patent/DK1594858T3/da active
- 2003-08-14 BR BRPI0313942A patent/BRPI0313942C1/pt not_active IP Right Cessation
- 2003-08-14 AU AU2003250499A patent/AU2003250499B2/en not_active Ceased
- 2003-08-14 KR KR1020077014809A patent/KR20070086768A/ko not_active Application Discontinuation
- 2003-08-14 EA EA200500174A patent/EA008448B1/ru not_active IP Right Cessation
- 2003-08-14 PL PL37767803A patent/PL377678A1/pl not_active Application Discontinuation
- 2003-08-14 KR KR20057003493A patent/KR100816166B1/ko active IP Right Grant
- 2003-08-14 GE GEAU2003008665 patent/GEP20064005B/en unknown
- 2003-08-14 EP EP20030791110 patent/EP1594858B1/en not_active Expired - Lifetime
- 2003-08-14 MX MXPA05001256A patent/MXPA05001256A/es active IP Right Grant
- 2003-08-14 OA OA1200500059A patent/OA12916A/en unknown
- 2003-08-14 WO PCT/IB2003/003634 patent/WO2004020431A2/en active Application Filing
- 2003-08-14 PT PT03791110T patent/PT1594858E/pt unknown
- 2003-08-14 AP AP2005003237A patent/AP2005003237A0/xx unknown
- 2003-08-19 DO DO2003000694A patent/DOP2003000694A/es unknown
- 2003-08-25 PE PE2003000864A patent/PE20050131A1/es active IP Right Grant
- 2003-08-25 HN HN2003000257A patent/HN2003000257A/es unknown
- 2003-08-26 MY MYPI20033225 patent/MY139357A/en unknown
- 2003-08-26 UY UY27952A patent/UY27952A1/es not_active Application Discontinuation
- 2003-08-26 AR ARP030103073 patent/AR041055A1/es unknown
- 2003-08-26 US US10/648,151 patent/US7071337B2/en active Active
- 2003-08-27 TW TW92123585A patent/TW200407131A/zh unknown
-
2005
- 2005-01-20 IS IS7660A patent/IS2738B/is unknown
- 2005-02-10 IL IL166832A patent/IL166832A/en active IP Right Grant
- 2005-02-14 CU CU20050031A patent/CU23413B7/es not_active IP Right Cessation
- 2005-02-22 CR CR7698A patent/CR7698A/es unknown
- 2005-02-28 HR HRP20050191AA patent/HRP20050191B1/hr not_active IP Right Cessation
- 2005-02-28 MA MA28124A patent/MA27389A1/fr unknown
- 2005-02-28 EC ECSP055633 patent/ECSP055633A/es unknown
- 2005-03-14 NO NO20051303A patent/NO20051303L/no not_active Application Discontinuation
- 2005-08-14 RS YUP-2005/0180A patent/RS20050180A/sr unknown
- 2005-11-18 HK HK05110348A patent/HK1078571A1/xx not_active IP Right Cessation
-
2009
- 2009-11-30 CY CY20091101249T patent/CY1110580T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PA8580301A1 (es) | Nuevos derivados de benzoimidazol utiles como agentes antiproliferativos | |
UY28135A1 (es) | Derivados de pirimidina para el tratamiento de crecimiento celular anormal | |
AR029634A1 (es) | Compuestos derivados heterociclicos utiles como agentes anticancerosos, composicion farmaceutica y procedimiento de tratamiento | |
PA8507601A1 (es) | Nuevos derivados de benzoimidazol utiles como agentes antiproliferativos | |
PA8487601A1 (es) | Derivados biciclicos sustituidos utiles como agentes contra el cancer | |
PA8480101A1 (es) | Derivados de quinolin-2-ona alquinilsustituidos utiles como agentes anticancerosos | |
UY26872A1 (es) | Derivados de la 4- fenil piridina | |
PA8490601A1 (es) | Derivados quinolin-2-ona sustituidos con heteroarilo utiles como agentes anticancerigenos. | |
PA8593001A1 (es) | Derivados de pirimidina para el tratamiento del crecimiento celular anormal | |
ECSP024393A (es) | Derivados biciclicos sustituidos para el tratamiento del crecimiento celular normal | |
UY26086A1 (es) | Procedimientos e intermedios para preparar compuestos anticancerosos | |
MX2007004183A (es) | Derivados de benzoimidazol utiles como agentes antiproliferacion. | |
EA200500018A1 (ru) | Бензконденсированные гетероариламидные производные тиенопиридинов, применяемые в качестве терапевтических агентов, фармацевтические композиции, включающие их, и способы их применения | |
ATE440834T1 (de) | Substituierte arylaminderivate und verwendungsverfahren | |
AR028810A1 (es) | Derivados de arilpiperazinil-ciclohexil indol, composiciones farmaceuticas que los comprenden y el uso de los mismos para la manufactura de medicamentos para el tratamiento de la depresion | |
UY27685A1 (es) | Indolil-urea derivados de tienopiridinas útiles como agentes antiangiogénicos, y procedimientos para su uso | |
UY27980A1 (es) | Indoles 2,7-sustituidos | |
DOP2002000519A (es) | Procedimiento para la preparación de derivados biciclicos sustituidos para el tratamiento del crecimiento celular anormal | |
UY26785A1 (es) | Derivados bicíclicos sustituidos para el tratamiento del crecimiento celular anormal | |
CL2004000744A1 (es) | Metodo para preparar derivados de fenilaminoquinazolinas; compuesto intermediario; y su metodo de preparacion. | |
UY27557A1 (es) | Procedimiento para la preparación de derivados biciclicos sustituidos para el tratamiento del crecimiento celular anormal. | |
ECSP993260A (es) | Derivados biciclicos sustituidos utiles como agentes contra el cancer | |
ECSP003793A (es) | Nuevos derivados de benzoimidazol utiles como agentes antiproliferativos | |
DOP2003000786A (es) | Derivados biciclicos para el tratamiento del crecimiento celular anormal. | |
ECSP003474A (es) | Derivados heterociclicos utiles como agentes anticancerosos |